微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文
$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447 Act: 34 Size: 709 KB 网页链接
$Nephros(NEPH)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-014448 Act: 34 Size: 1 MB 网页链接
$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442 Act: 34 Size: 1 MB 网页链接
$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107 Act: 34 Size: 7 MB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012 Size: 12 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011 Size: 6 KB 网页链接
$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009216 Act: 34 Size: 345 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022642 Size: 4 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022644 Size: 11 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022643 Size: 7 KB 网页链接